Literature DB >> 13499892

Saturated synthetic lecithins in VDRL and Kolmer antigens for the sero-diagnosis of syphilis.

D B TONKS, R H ALLEN.   

Abstract

Entities:  

Keywords:  LECITHIN; SYPHILIS/diagnosis

Mesh:

Substances:

Year:  1957        PMID: 13499892      PMCID: PMC1054176          DOI: 10.1136/sti.33.4.249

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  7 in total

1.  Serological, nephelometrical, and statistical studies on the employment of synthetic lecithin in cardiolipin antigens.

Authors:  A REYN; M W BENTZON; J HARTMANN
Journal:  Br J Vener Dis       Date:  1956-03

2.  Use of synthetic, crystalline, L-alpha-dimyristoyl lecithin in cardiolipin antigens.

Authors:  A REYN; M W BENTZON
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

3.  [Not Available].

Authors:  M FAURE; C DE LA VAISSIERE
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

4.  The use of some synthetic phosphatides in antigens for the serodiagnosis of syphilis.

Authors:  D B TONKS; R H ALLEN
Journal:  Science       Date:  1953-07-10       Impact factor: 47.728

5.  [Comparison of the serological activity of egg yolk lecithin and of synthetic betaalpha-dimyristoly lecithin, each combined with cardiolipin, in the serodiagnosis of syphilis].

Authors:  M FAURE
Journal:  Ann Inst Pasteur (Paris)       Date:  1952-06

6.  Cardiolipin antigens in the serodiagnosis of syphilis.

Authors:  R H ALLEN; M A MASON
Journal:  Can J Public Health       Date:  1952-03

7.  The value of synthetic (dimyristoyl) L-a-lecithin as an antigen component with cardiolipin in the serodiagnosis of syphilis; preliminary report.

Authors:  B S KLINE
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1950-09-05
  7 in total
  1 in total

1.  Pure phosphatides and the serodiagnosis of syphilis: relation of chemical structure to reactivity.

Authors:  R H ALLEN; D B TONKS
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.